MK0686 in Postsurgery Dental Pain

This study has been completed.

Sponsored by:	Merck
Information provided by:	Merck
ClinicalTrials.gov Identifier:	NCT00533403

Purpose

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Condition	Intervention	Phase
Pain, Postoperative	Drug: MK0686	Phase II

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study

Further study details as provided by Merck:

Study Start Date:	June 2004
Study Completion Date:	June 2004

Eligibility

Criteria

Inclusion Criteria:

Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion Criteria:

Patient has history of heart disease, asthma, pulmonary disease
Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00533403

Sponsors and Collaborators

Merck

Investigators

Study Director:

Medical Monitor

Merck

More Information

Study ID Numbers:	2007_617
Study First Received:	September 19, 2007
Last Updated:	September 19, 2007
ClinicalTrials.gov Identifier:	NCT00533403
Health Authority:	United States: Food and Drug Administration

Study placed in the following topic categories:

Signs and Symptoms
Postoperative Complications
Toothache
Pain
Pain, Postoperative

Additional relevant MeSH terms:

Pathologic Processes

ClinicalTrials.gov processed this record on January 16, 2009